New Therapeutic Strategies in Lung Cancers

Editors: Peters, Solange, Besse, Benjamin (Eds.)

  • An educational presentation to help the reader understanding the new concepts of lung cancer and their implementation in their daily practice
  • A unique presentation of recent developments and future perspectives
  • An up-to-date review of current management of NSCLC
  • Written by international experts
see more benefits

Buy this book

eBook $79.99
price for USA (gross)
  • ISBN 978-3-319-06062-0
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $109.00
price for USA
  • ISBN 978-3-319-06061-3
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $109.00
price for USA
  • Customers within the U.S. and Canada please contact Customer Service at 1-800-777-4643, Latin America please contact us at +1-212-460-1500 (Weekdays 8:30am – 5:30pm ET) to place your order.
  • Due: August 30, 2016
  • ISBN 978-3-319-35409-5
  • Free shipping for individuals worldwide
About this book

This book provides an up-to-date review of current management techniques for Non-Small Cell Lung Cancer. It addresses all of the latest issues that have been raised by the discovery of oncogenic drivers and the improvement of diagnosis and therapeutic methods, including new radiotherapy techniques and anticancer strategies like immunotherapy. New strategies for patients with molecular alterations and the management of particular types of cases are also highlighted.
Written by recognized experts in their field, the book represents a unique and valuable resource in the field of lung cancer, both for those currently in training and for those already in clinical or research practice.

About the authors

Solange Peters, MD-PhD, PD-MER, is in charge of the thoracic malignancies program in the Department of Oncology of the University of Lausanne and active in building a translational program in collaboration with the molecular oncology laboratory directed by Prof. D. Hanahan and Prof. E. Meylan as well as the Ludwig Institute. Her main field of interest is new biomarker discovery and validation in preclinical and clinical settings. She is also heavily involved and interested in developing multimodality trials for locally advanced NSCLC. She is co-chair of the Swiss lung cancer research group (SAKK) and Scientific Coordinator as well as Chair of the Informatics Committee of the European Thoracic Oncology Platform (ETOP). She has been elected the Swiss national representative of ESMO in 2013.

Dr Benjamin Besse is a cancer specialist, Head of the Thoracic Oncology Unit at the Institut Gustave Roussy in France. His main research interests are application of molecular abnormalities to personalize treatment, phase I trials in thoracic tumors and thymic tumors. He has been the main Investigator of more than 30 phase I and phase II trials in the past 5 years. He coordinates the French network for thymic malignancies. He is associate editor of European Respiratory Journal. He was the coordinating author for the ESMO Guidelines Working Group on Non-Small Cell Lung Cancer (NSCLC) and is Chair of the systemic treatment part of the 2013 ESMO Consensus Conference on Lung Cancer. He is member of the administrative board of the French Intergroup for Thoracic Oncology (IFCT) and Member of ASCO, ESMO and IASLC.

Reviews

From the book reviews:

“This brief book addresses current research and practice in the treatment of local, locally advanced, and metastatic lung cancer. … The audience appears to be experienced clinical and research thoracic surgeons and radiation and medical oncologists with a special interest in the critically important topic of treatment of lung cancer. It should also be of great value to trainees in these fields. … Chapters in this book are scholarly, encyclopedic in scope, and provide comprehensive bibliographic references.” (Fred Grannis, Doody’s Book Reviews, February, 2015)

Table of contents (16 chapters)

  • Lung Cancer Screening

    Field, John K.

    Pages 1-11

  • Integrated PET/CT and Linear Endosonography (EBUS and EUS)

    Dooms, Christophe (et al.)

    Pages 15-23

  • Minimally Invasive Surgery for Early NSCLC

    Louie, Brian E. (et al.)

    Pages 27-32

  • Stereotaxic Body Radiotherapy for Stage I NSCLC

    Guckenberger, Matthias

    Pages 33-48

  • How to Personalize Perioperative Chemotherapy in Early Non-small Cell Lung Cancer?

    Carnio, Simona (et al.)

    Pages 49-66

Buy this book

eBook $79.99
price for USA (gross)
  • ISBN 978-3-319-06062-0
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $109.00
price for USA
  • ISBN 978-3-319-06061-3
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $109.00
price for USA
  • Customers within the U.S. and Canada please contact Customer Service at 1-800-777-4643, Latin America please contact us at +1-212-460-1500 (Weekdays 8:30am – 5:30pm ET) to place your order.
  • Due: August 30, 2016
  • ISBN 978-3-319-35409-5
  • Free shipping for individuals worldwide
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
New Therapeutic Strategies in Lung Cancers
Editors
  • Solange Peters
  • Benjamin Besse
Copyright
2015
Publisher
Springer International Publishing
Copyright Holder
Springer International Publishing Switzerland
eBook ISBN
978-3-319-06062-0
DOI
10.1007/978-3-319-06062-0
Hardcover ISBN
978-3-319-06061-3
Softcover ISBN
978-3-319-35409-5
Edition Number
1
Number of Pages
XII, 255
Number of Illustrations and Tables
9 b/w illustrations, 14 illustrations in colour
Topics